QUFU, China, Nov. 30, 2011 /PRNewswire/ -- Sunwin International Neutraceuticals, Inc. "Sunwin International" (OTC.BB: SUWN), one of the top global providers of high quality stevia extracts including Rebaudioside A 98, announced today that its stevia extracts production process has been certified organic under standards established by the USDA National Organic Program and European Commission (EC) 834/2007 and EC 889/2008.
Sunwin International achieved these certifications after undergoing an extensive audit in 2011 by CERES GmbH, an international organization that specializes in inspection and certification in the areas of organic farming and food processing. Sunwin's stevia extracts production process is certified to be free of synthetic chemical inputs and uses clean and sanitized procedures that avoid chemical contamination.
Commenting on the certifications, Ms.Dongdong Lin, CEO of Sunwin International, stated "We have taken great care to ensure that our production process for stevia extracts achieved these important standards. As stevia is an all natural and low calorie sweetener as compared to products like sucralose, it is important that we have gone a step further than other producers by having our process certified as organic. With the food and beverage industry in the U.S. and Europe continuing to move toward organic, all natural and low calorie products, these certifications will only enhance our position as a Stevia producer along with our distribution partners around the world."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine and zero calorie natural sweeteners (Sunwin Stevia' Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit http://www.sunwininternational.com.
Contact:
Lillian Wong
U.S. Representative
954-363-7333
ir@sunwininternational.com
Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding revenues, net income and earnings.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2011.
SOURCE Sunwin International Neutraceuticals, Inc.
